 there would be a potential, I think, for using very large-scale data to get some insights from existing drug trials that the FDA will eventually end up approving. And as it currently stands, so many drug trials are conducted and loads of them are false. But then you get, say you conduct five drug trials on a particular drug, one of those will be positive and it will show efficacy of the drug and the other four do not.